Literature DB >> 17200209

Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human.

Paola Alberici1, Emma de Pater, Joana Cardoso, Mieke Bevelander, Lia Molenaar, Jos Jonkers, Riccardo Fodde.   

Abstract

Although chromosomal instability characterizes the majority of human colorectal cancers, the contribution of genes such as adenomatous polyposis coli (APC), KRAS, and p53 to this form of genetic instability is still under debate. Here, we have assessed chromosomal imbalances in tumors from mouse models of intestinal cancer, namely Apc(+/1638N), Apc(+/1638N)/KRAS(V12G), and Apc(+/1638N)/Tp53-/-, by array comparative genomic hybridization. All intestinal adenomas from Apc(+/1638N) mice displayed chromosomal alterations, thus confirming the presence of a chromosomal instability defect at early stages of the adenoma-carcinoma sequence. Moreover, loss of the Tp53 tumor suppressor gene, but not KRAS oncogenic activation, results in an increase of gains and losses of whole chromosomes in the Apc-mutant genetic background. Comparative analysis of the overall genomic alterations found in mouse intestinal tumors allowed us to identify a subset of loci syntenic with human chromosomal regions (eg, 1p34-p36, 12q24, 9q34, and 22q) frequently gained or lost in familial adenomas and sporadic colorectal cancers. The latter indicate that, during intestinal tumor development, the genetic mechanisms and the underlying functional defects are conserved across species. Hence, our array comparative genomic hybridization analysis of Apc-mutant intestinal tumors allows the definition of minimal aneuploidy regions conserved between mouse and human and likely to encompass rate-limiting genes for intestinal tumor initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200209      PMCID: PMC1762685          DOI: 10.2353/ajpath.2007.060853

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  72 in total

1.  DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones.

Authors:  Heike Fiegler; Philippa Carr; Eleanor J Douglas; Deborah C Burford; Sarah Hunt; Carol E Scott; James Smith; David Vetrie; Patricia Gorman; Ian P M Tomlinson; Nigel P Carter
Journal:  Genes Chromosomes Cancer       Date:  2003-04       Impact factor: 5.006

2.  A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization.

Authors:  Yeun-Jun Chung; Jos Jonkers; Hannah Kitson; Heike Fiegler; Sean Humphray; Carol Scott; Sarah Hunt; Yuejin Yu; Ichiko Nishijima; Arno Velds; Henne Holstege; Nigel Carter; Allan Bradley
Journal:  Genome Res       Date:  2004-01       Impact factor: 9.043

3.  Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma.

Authors:  Angela M Jones; Eleanor J Douglas; Sarah Er Halford; Heike Fiegler; Patricia A Gorman; Rebecca R Roylance; Nigel P Carter; Ian P M Tomlinson
Journal:  Oncogene       Date:  2005-01-06       Impact factor: 9.867

4.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 5.  MAD2 dependent mitotic checkpoint defects in tumorigenesis and tumor cell death: a double edged sword.

Authors:  Loren Michel; Robert Benezra; Elena Diaz-Rodriguez
Journal:  Cell Cycle       Date:  2004-08-25       Impact factor: 4.534

Review 6.  hCDC4 and genetic instability in cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Cell Cycle       Date:  2004-06-14       Impact factor: 4.534

7.  High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.

Authors:  Kentaro Nakao; Kshama R Mehta; Jane Fridlyand; Dan H Moore; Ajay N Jain; Amalia Lafuente; John W Wiencke; Jonathan P Terdiman; Frederic M Waldman
Journal:  Carcinogenesis       Date:  2004-03-04       Impact factor: 4.944

8.  Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.

Authors:  Tamostu Sugai; Hiroshi Takahashi; Wataru Habano; Shin-ichi Nakamura; Kimihiko Sato; Seishi Orii; Kazuyuki Suzuki
Journal:  J Pathol       Date:  2003-06       Impact factor: 7.996

9.  Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas.

Authors:  Amy Leslie; Norman R Pratt; Karen Gillespie; Mark Sales; Neil M Kernohan; Gillian Smith; C Roland Wolf; Francis A Carey; Robert J C Steele
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

10.  Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC.

Authors:  Rebecca A Green; Kenneth B Kaplan
Journal:  J Cell Biol       Date:  2003-12-08       Impact factor: 10.539

View more
  7 in total

1.  Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers.

Authors:  Guangjun Zhang; Sebastian Hoersch; Adam Amsterdam; Charles A Whittaker; Jacqueline A Lees; Nancy Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

2.  Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway.

Authors:  Richard B Halberg; Jesse Waggoner; Kristen Rasmussen; Alanna White; Linda Clipson; Amy J Prunuske; Jeffery W Bacher; Ruth Sullivan; Mary Kay Washington; Henry C Pitot; John H J Petrini; Donna G Albertson; William F Dove
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

3.  Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis.

Authors:  H Nikki March; Alistair G Rust; Nicholas A Wright; Jelle ten Hoeve; Jeroen de Ridder; Matthew Eldridge; Louise van der Weyden; Anton Berns; Jules Gadiot; Anthony Uren; Richard Kemp; Mark J Arends; Lodewyk F A Wessels; Douglas J Winton; David J Adams
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 38.330

Review 4.  Tumor suppressor genes in familial adenomatous polyposis.

Authors:  Nahal Eshghifar; Naser Farrokhi; Tahereh Naji; Mohammadreza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

5.  Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis.

Authors:  L van der Weyden; M J Arends; O M Dovey; H L Harrison; G Lefebvre; N Conte; F V Gergely; A Bradley; D J Adams
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

6.  Adenomatous polyposis coli in cancer and therapeutic implications.

Authors:  Olivia Noe; Louis Filipiak; Rachel Royfman; Austin Campbell; Leslie Lin; Danae Hamouda; Laura Stanbery; John Nemunaitis
Journal:  Oncol Rev       Date:  2021-06-24

7.  Smad4 haploinsufficiency: a matter of dosage.

Authors:  Paola Alberici; Claudia Gaspar; Patrick Franken; Marcin M Gorski; Ingrid de Vries; Rodney J Scott; Ari Ristimäki; Lauri A Aaltonen; Riccardo Fodde
Journal:  Pathogenetics       Date:  2008-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.